Patent ID: 9370483
Filing Date: 2016-06-21
CPC Classification: A61K

Claim Text:
1. A stable fixed dose aqueous pharmaceutical composition for nasal administration to a human, the composition being a suspension which comprises (a) mometasone or its salt in particulate form; (b) olopatadine or its salt in dissolved form; wherein the pharmaceutical composition, upon nasal administration of a dose equivalent to 2400 mcg of olopatadine or its salt to a human, results in (a) an area under the curve (AUC) 0-∞ for olopatadine or its salt of about 42.5 ng·hr/mL to about 116.5 ng·hr/mL, (b) a C max for olopatadine or its salt of about 10.3 ng/mL to about 24.1 ng/ml, or (c) any combination of any of the foregoing.